Found: 502
Select item for more details and to access through your institution.
Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model.
- Published in:
- Cardiovascular Toxicology, 2024, v. 24, n. 7, p. 656, doi. 10.1007/s12012-024-09872-3
- By:
- Publication type:
- Article
Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review.
- Published in:
- Cardiovascular Toxicology, 2022, v. 22, n. 3, p. 268, doi. 10.1007/s12012-021-09703-9
- By:
- Publication type:
- Article
Frontispiz: Catalytic Asymmetric Synthesis of the anti‐COVID‐19 Drug Remdesivir.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 47, p. 1, doi. 10.1002/ange.202084761
- By:
- Publication type:
- Article
Catalytic Asymmetric Synthesis of the anti‐COVID‐19 Drug Remdesivir.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 47, p. 21000, doi. 10.1002/ange.202011527
- By:
- Publication type:
- Article
Comparative study between the therapeutic effect of remdesivir versus hydroxychloroquine in COVID-19 hospitalized patients.
- Published in:
- Microbes & Infectious Diseases, 2021, v. 2, n. 4, p. 642, doi. 10.21608/MID.2021.85877.1177
- By:
- Publication type:
- Article
ADME predictions and molecular docking study of some compounds and drugs as potential inhibitors of COVID-19 main protease: A virtual study as comparison of computational results.
- Published in:
- Medicine Science, 2021, v. 10, n. 1, p. 18, doi. 10.5455/medscience.2020.09.203
- By:
- Publication type:
- Article
Is There Enough Evidence to Avoid Remdesivir Use in Patients with Severe Renal Impairment? A Review of the Pharmacological and Clinical Literature.
- Published in:
- Mediterranean Journal of Infection, Microbes & Antimicrobials, 2021, v. 10, p. 60, doi. 10.4274/mjima.galenos.2021.2021.14
- By:
- Publication type:
- Article
THE ROLE OF AGE AND COMORBIDITIES ON THE OUTCOME OF CONFIRMED CLINICALLY CRITICAL COVID-19 PATIENTS TREATED WITH REMDESIVIR AT INDONESIA'S NATIONAL REFERRAL HOSPITAL.
- Published in:
- African Journal of Infectious Diseases, 2023, v. 17, n. 1, p. 55, doi. 10.21010/Ajidv17i1.5
- By:
- Publication type:
- Article
Research towards treating COVID-19.
- Published in:
- British Journal of Community Nursing, 2020, v. 25, n. 4, p. 204, doi. 10.12968/bjcn.2020.25.4.204
- By:
- Publication type:
- Article
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae202
- By:
- Publication type:
- Article
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 10, p. 1, doi. 10.1093/ofid/ofad482
- By:
- Publication type:
- Article
Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 10, p. 1, doi. 10.1093/ofid/ofac502
- By:
- Publication type:
- Article
Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac382
- By:
- Publication type:
- Article
Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab391
- By:
- Publication type:
- Article
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab153
- By:
- Publication type:
- Article
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab278
- By:
- Publication type:
- Article
A Case of Severe Acute Respiratory Syndrome Coronavirus 2 Treatment With Remdesivir in a Hepatitis C-Coinfected Patient Resulting in Temporary Viral Control and Posttreatment Flare.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 4, p. 1, doi. 10.1093/ofid/ofab100
- By:
- Publication type:
- Article
Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 11, p. 1, doi. 10.1093/ofid/ofaa481
- By:
- Publication type:
- Article
Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 10, p. 1, doi. 10.1093/ofid/ofaa319
- By:
- Publication type:
- Article
Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 9, p. 1, doi. 10.1093/ofid/ofaa345
- By:
- Publication type:
- Article
The problem with relying on profit-driven models to produce pandemic drugs.
- Published in:
- Journal of Law & the Biosciences, 2020, v. 7, n. 1, p. 1, doi. 10.1093/jlb/lsaa060
- By:
- Publication type:
- Article
P5‐47: Safety and efficacy of remdesivir, baricitinib and high‐dose steroid combination therapy in patients hospitalized with COVID‐19.
- Published in:
- Respirology, 2021, v. 26, p. 175, doi. 10.1111/resp.14150_254
- Publication type:
- Article
O8‐3: The effectiveness of the combined use of remdesivir and regdanvimab (CT‐P59) in patients with severe COVID‐19: A single center retrospective study.
- Published in:
- Respirology, 2021, v. 26, p. 23, doi. 10.1111/resp.14149_46
- Publication type:
- Article
P5‐47: Safety and efficacy of remdesivir, baricitinib and high‐dose steroid combination therapy in patients hospitalized with COVID‐19.
- Published in:
- Respirology, 2021, v. 26, p. 175, doi. 10.1111/resp.14150_254
- Publication type:
- Article
O8‐3: The effectiveness of the combined use of remdesivir and regdanvimab (CT‐P59) in patients with severe COVID‐19: A single center retrospective study.
- Published in:
- Respirology, 2021, v. 26, p. 23, doi. 10.1111/resp.14149_46
- Publication type:
- Article
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13680-6
- By:
- Publication type:
- Article
Optimizing antiviral therapy for COVID-19 with learned pathogenic model.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10929-y
- By:
- Publication type:
- Article
Acute pancreatitis or severe increase in pancreatic enzyme levels following remdesivir administration in COVID-19 patients: an observational study.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09170-4
- By:
- Publication type:
- Article
Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02972-y
- By:
- Publication type:
- Article
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 7, p. 1703, doi. 10.1007/s40121-024-00991-6
- By:
- Publication type:
- Article
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 7, p. 1589, doi. 10.1007/s40121-024-00994-3
- By:
- Publication type:
- Article
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 4, p. 715, doi. 10.1007/s40121-024-00938-x
- By:
- Publication type:
- Article
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 10, p. 2471, doi. 10.1007/s40121-023-00874-2
- By:
- Publication type:
- Article
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 6, p. 1655, doi. 10.1007/s40121-023-00816-y
- By:
- Publication type:
- Article
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 4, p. 1189, doi. 10.1007/s40121-023-00789-y
- By:
- Publication type:
- Article
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 1, p. 257, doi. 10.1007/s40121-022-00729-2
- By:
- Publication type:
- Article
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 3, p. 525, doi. 10.1007/s40121-020-00318-1
- By:
- Publication type:
- Article
Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1072202
- By:
- Publication type:
- Article
In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.973768
- By:
- Publication type:
- Article
Erratum: Remdesivir strongly binds to RNA-dependent RNA polymerase, membrane protein, and main protease of SARS-CoV-2: Indication from molecular modeling and simulations.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1027099
- Publication type:
- Article
Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.971890
- By:
- Publication type:
- Article
Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.690726
- By:
- Publication type:
- Article
Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.692828
- By:
- Publication type:
- Article
مقایسه کارایی تابشهای فرابنفش خالء و C در تجزیه داروی رمدسیویر موجود در آب آلوده...
- Published in:
- Iranian Journal of Health & Environment, 2023, v. 16, n. 1, p. 129
- By:
- Publication type:
- Article
Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33825-5
- By:
- Publication type:
- Article
Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System.
- Published in:
- International Journal of Clinical Pharmacy, 2023, v. 45, n. 2, p. 509, doi. 10.1007/s11096-023-01554-4
- By:
- Publication type:
- Article
A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR.
- Published in:
- Journal of Pharmaceutical Negative Results, 2022, v. 13, p. 217, doi. 10.47750/pnr.2022.13.S09.026
- By:
- Publication type:
- Article
Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients with COVID-19.
- Published in:
- Journal of Pharmaceutical Negative Results, 2022, v. 13, n. 2, p. 82, doi. 10.47750/pnr.2022.13.02.012
- By:
- Publication type:
- Article
Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 9, p. 2229, doi. 10.3390/pharmaceutics15092229
- By:
- Publication type:
- Article